Discovery and development of novel melanogenic drugs. Melanotan-I and -II.

Pharmaceutical biotechnology

Volumn 11, Issue , 1998, Pages 575-595

  Hadley, M E ^a   Hruby, V J ^a   Blanchard, J ^a   Dorr, R T ^a   Levine, N ^a   Dawson, B V ^a   al Obeidi, F ^a   Sawyer, T K ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ANTINEOPLASTIC AGENT; CYCLOPEPTIDE; DRUG DERIVATIVE; MELANOTAN II; MELANOTAN-II; MSH, 4 NLE 7 PHE ALPHA; MSH, 4-NLE-7-PHE-ALPHA-;

AMINO ACID SEQUENCE; ANIMAL; DRUG DESIGN; HUMAN; MOLECULAR GENETICS; REVIEW; STRUCTURE ACTIVITY RELATION;

ALPHA-MSH; AMINO ACID SEQUENCE; ANIMALS; ANTICARCINOGENIC AGENTS; DRUG DESIGN; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES, CYCLIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031609839     PISSN: 10780467     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)